Skip to main content
Log in

Long term effects of intra-articular botulinum toxin a for refractory joint pain

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

The purpose of this case series review is to describe our 12 month clinical experience with intra-articular injections of Botulinum toxin Type A (BoNT/A) for refractory joint pain. Eleven patients with chronic arthritis who had failed treatment with oral and/or intra-articular medications and were not surgical candidates were referred to us for management of moderate to severe refractory joint pain in 15 joints. The use of BoNT/A to treat joint pain is a non-FDA approved “off label” treatment with potential side effects. After a detailed explanation of the joint injection procedure, signed informed consent was obtained for the procedure. Fifteen joints were injected with BoNT/A (Allergan, Inc): six lower extremity joints (3 knees, 3 ankles) with 25-50 units and nine shoulders with 50-100 units. Patients were followed for one year or longer. Maximum relief of pain was measured by comparing baseline pain on a numeric rating scale (0-10) to pain at the time of maximum relief (paired t-test). Maximum improvement in function was assessed using paired t-tests for improvement in active flexion and abduction for the shoulder joint, and by the time to perform sit to stand ten times (the timed stands test, TST) for the lower extremity joints.

Results: Two patients were female and nine were male, aged 42-82 years. Five had osteoarthritis (OA), five had rheumatoid arthritis (RA) and one had psoriatic arthritis. All patients were on analgesic and/or anti-inflammatory medications and all joints had previous intra-articular steroid or viscosupplement injections with inadequate or unsatisfactory benefit. A clinically and statistically significant improvement was noted after IA-BoNT/ A injections. The mean maximum decrease in lower extremity joint pain was 55% (p =0.02) and the 36% (p =0.044) improvement in the Timed Stands Test was noted at four to ten weeks after injection. There was a 71% mean maximum reduction in shoulder pain severity from 8.2 ± 1.1 to 2.4 ± 1.9 (p <0.001). Active range of motion increased 67% in flexion (from 67.8 ± 27.6 to 113.3 ± 46.6 degrees, p =0.001) and 42% in abduction (from 50 18.5 degrees to 71.1 ± 23.1 degrees p =0.01). No immediate or delayed adverse effects related to BoNT/A were noted after the injection. Duration of pain relief was variable and ranged from 3 to 12 months. Five joints were re-injected with IA-BoNT/A and had a similar decrease in joint pain that lasted 3 to 12 months. Conclusions: This is the first report of the long term effects of intra-articular BoNT/A injections to treat chronic joint pain and the efficacy of repeated injections. Although this study was small, and uncontrolled the results suggest that IA-BoNT/ A injections are an effective and safe treatment for chronic joint pain disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adebajo AO, P Nash and BL Hazleman (1990) A prospective double blind dummy placebo controlled study comparing tri-amcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis.J. Rheumatol. 17(9), 1207–1210.

    CAS  PubMed  Google Scholar 

  • Alper BS and PR Lewis (2002) Review: tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for posther-petic neuralgia.J. Fam. Pract. 51, 121–128.

    PubMed  Google Scholar 

  • American College of Rheumatology (2000) Recommendations for the medical management of osteoarthritis of the hip and knee, 2000 Update. ACR Subcommittee on Osteoarthritis Guidelines.Arth. Rheum. 43, 1905–1915.

    Article  Google Scholar 

  • American Pain Society (2002)Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis, 2nd Edition (American Pain Society: Glenview, IL), pp 1–184.

    Google Scholar 

  • Aoki KR (2003) Evidence for antinociceptive activity of botulinum toxin type A in pain management.Headache 43 Suppl. 1, S9-S15.

    Article  PubMed  Google Scholar 

  • Arezzo J (2002) Possible mechanisms for the effects of Botulinum toxin on pain.Clin. J. Pain 18 (Suppl), S125-S132.

    Article  PubMed  Google Scholar 

  • Bergenudd H, F Lindgarde, B Nilsson and CJ Petersson (1988) Shoulder pain in middle age. A study of prevalence and relation to occupational work load and psychosocial factors.Clin. Orthop. 231, 234–238.

    PubMed  Google Scholar 

  • Berry H, L Fernandes, B Bloom, RJ Clark and EB Hamilton (1980) Clinical study comparing acupuncture, physiotherapy, injection and oral anti-inflammatory therapy in shoulder-cuff lesions.Curr. Med. Res. Opin. 7(2), 121–126.

    Article  CAS  PubMed  Google Scholar 

  • Binder A, G Parr, B Hazleman and S Fitton-Jackson (1984) Pulsed electromagnetic field therapy of persistent rotator cuff tendinitis. A double-blind controlled assessment.Lancet 1(8379), 695–698.

    Article  CAS  PubMed  Google Scholar 

  • Bjelle A (1989) Ageing and disorders of the locomotor system.Scand. J. Rheumatol. Suppl.82, 3–12. Review.

    Article  CAS  PubMed  Google Scholar 

  • Blomqvist P, N Feltelius, A Ekbom and L Klareskog (2000) Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.J. Rheumatology 27(5), 1171–1177.

    CAS  Google Scholar 

  • Brashear A, M Gordon, E Elovic, V Kassicieh, M Do, C Lee, S Jenkins and C Turkel (2002) Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.N. Engl. J. Med. 347, 395–400.

    Article  CAS  PubMed  Google Scholar 

  • Brin M (1997) Botulinum toxin: chenistry, pharmacology, toxiciy, and immunology.Muscle Nerve 6 (Suppl.), S146-S168.

    Article  CAS  PubMed  Google Scholar 

  • Brin MF, S Fahn, C Moskowitz, A Friedman, H M Shale, PE Greene, A Blitzer, T List, D Lange, RE Lovelaceet al. (1987) Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.Mov. Disord. 2(4), 237–254.

    Article  CAS  PubMed  Google Scholar 

  • Brin MF, S Fahn, C Moskowitz, A Friedman, HM Shale, PE Greene, A Blitzer, T List, D Lange, RE Lovelaceet al. (1988) Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.Adv. Neurol. 50, 599–608.

    CAS  PubMed  Google Scholar 

  • Brin MF, MF Lew, CH Adler, CL Comella, SA Factor, J Jankovic, C O’Brien, JJ Murray, JD Wallace, A Willmer-Hulme and M Koller (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.Neurology 53(7), 1431–1438.

    Article  CAS  PubMed  Google Scholar 

  • Chakravarty KK and M Webley (1990) Disorders of the shoulder: an often unrecognised cause of disability in elderly people.Bmj 300(6728), 848–849.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chard MD, BL Hazleman and MD Devereux (1988) Controlled trial to investigate dose-response patterns to portable pulsed electromagnetic fields in the treatment of rotator cuff tendinitis.J. Orthop. Rheumatol. 1, 33–40.

    Google Scholar 

  • Chard MD, R Hazleman, BL Hazleman, RH King and BB Reiss (1991) Shoulder disorders in the elderly: a community survey.Arthritis Rheum. 34(6), 766–769.

    Article  CAS  PubMed  Google Scholar 

  • Clements P and P. He (1997)Nonsteroidal Antirheumatic Drugs. Textbook of Rheumatology (Kelley W, S Ruddy, E Harris and C Sledge, Eds.) (WB Saunders: Philadelphia, PA)1, 707–740.

    Google Scholar 

  • Comella CL, J Jankovic and MF Brin (2000) Use of botulinum toxin type A in the treatment of cervical dystonia.Neurology 55 (Suppl. 5), S15-S21.

    CAS  PubMed  Google Scholar 

  • Cui M, Z Li, S You, S Khanijou and K Aoki (2002) Mechanisms of the antinociceptive effect of subcutaneous Botox: inhibition of peripheral and central nociceptive processing.Arch. Pharmacol. 365 (Suppl. 2), R17.

    Google Scholar 

  • Cui M, S Khanijou, J Rubino and R Aoki (2004) Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.Pain 107, 125–133.

    Article  CAS  PubMed  Google Scholar 

  • Dionne RA and J Witter (2003) NIH-FDA Analgesic Drug Development Workshop: translating scientific advances into improved pain relief.Clin. J. Pain 19(3), 139–147.

    Article  PubMed  Google Scholar 

  • Dolly O (2003) Synaptic transmission: inhibition of neurotrans-mitter release by botulinum toxins.Headache 43 (Suppl. 1), S16-S24.

    Article  PubMed  Google Scholar 

  • Dolly JO, AC Ashton, C McInnes, JD Wadsworth, B Poulain, L Tauc, CC Shone and J Melling (1990) Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.J. Physiol. (Paris) 84(3), 237–246.

    CAS  Google Scholar 

  • Durham P (2003) Mechanism of botulinum toxin type-A inhibition of calcitonin gene-related peptide (CGRP) secretion from trigeminal nerve cells.Intl. Headache Soc., Rome, Italy.

  • Dykstra D and A Sidi (1990) Treatment of detrusor-sphincter dys-snergia with botulinum A toxin: a double blind study.Arch. Phys. Med. Rehabil. 71, 24–26.

    CAS  PubMed  Google Scholar 

  • Dykstra D, J. Pryor and G Goldish (1993) Use of botulinum toxin type B for the treatment of detrussor hyperreflexia in a patient with multiple sclerosis.Arch. Phys. Med. Rehabil. 84, 1399–1400.

    Article  Google Scholar 

  • Dykstra DD, M Stucky, S Schimpff, ML Mahowald and JA Singh (2005) Effects of intra-articular botulinum toxin type A for sacroiliac, cervical/lumbar facet and costosternal joint pain and C-2 root and lumbar disc pain. 5th Intl. Conf. onBasic and Therapeutic Aspectss of Botulinum and Tetanus Toxins, Denver, CO, USA..

  • Ettinger W, M Davis, J Neurhaus and K Mallon (1994) Long-term physical functioning in persons with knee osteoarthritis from NHANESI: effects of comorbid medical conditions.J. Clin. Epidemiol. 47, 809–815.

    Article  CAS  PubMed  Google Scholar 

  • Fagien S (1999) Botox for the treatment of dynamic and hyperki-netic facial lines and furrows: adjunctive use in facial aesthetic surgery.Plast. Reconstr. Surg. 103, 701–713.

    Article  CAS  PubMed  Google Scholar 

  • Farrar JT, RK Portenoy, JA Berlin, JL Kinman and BL Strom (2000) Defining the clinically important difference in pain outcome measures.Pain 88(3), 287–294.

    Article  CAS  PubMed  Google Scholar 

  • Farrar JT, JP Young, L LaMoreaux, JL Werth and RM Poole (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.Pain 94, 149–158.

    Article  CAS  PubMed  Google Scholar 

  • First ER (2000) Application of botulinum toxin to the management of neurogenic inflammatory disorders. 4921757,5670484, 5674205,5677274,5714468. US, FIRST, ERIC R. 000923884, 1-7.

  • Gartsman GM (1993) The shoulder: common clinical problems.Semin. Perioper. Nurs. 2(2), 75–81.

    CAS  PubMed  Google Scholar 

  • Gobel H, A Heinze, K Heinze-Kuhn and W Jost (2001) Evidence based medicine: botulinum toxin A in migraine and tension type headache.J. Neurol. 248 (Suppl.), 34–38.

    Article  CAS  PubMed  Google Scholar 

  • Green S, R Buchbinder, R Glazier and A Forbes (2003a) Interventions for shoulder pain.Cochrane Database Syst. Rev. (1).

  • Green S, R Buchbinder and S Hetrick (2003b) Physiotherapy interventions for shoulder pain.Cochrane Database Syst. Rev. (2), CD004258.

  • Hallet M (1999) One man’s poison — clinical applications of botulinum toxin.N. Engl. J. Med. 341, 118–120.

    Article  Google Scholar 

  • Hay EM, E Thomas, SM Paterson, K Dziedzic and PR Croft (2003) A pragmatic randomised controlled trial of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care.Ann. Rheum. Dis. 62(5), 394–399.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hochberg M (2003) Multidisciplinary integrative approach to treating knee pain in patients with osteoarthritis.Ann. Int. Med. 139, 781–783.

    Article  PubMed  Google Scholar 

  • Jankovic J and K Schwartz (1990) Botulinum toxin injections for cervical dystonia.Neurology 40, 277–280.

    Article  CAS  PubMed  Google Scholar 

  • Keizer S, H Rutten, P Pilot, H Morre, J v Os and A Verburg (2002) Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study.Clin. Orthop. 401, 125–131.

    Article  PubMed  Google Scholar 

  • Lang AM (2002) Botulinum toxin therapy for myofascial pain disorders.Curr. Pain Headache Rep. 6(5), 355–360.

    Article  PubMed  Google Scholar 

  • Lang AM (2003) Botulinum toxin type A therapy in chronic pain disorders.Arch. Phys. Med. Rehabil. 84 (Suppl. 1), S69-S73; quiz S74-S75.

    Article  PubMed  Google Scholar 

  • Mahowald M (2000) The role of nonprescription analgesics in treating mild to moderate pain. Clinical and economic considerations.Minneapolis, Health Learning Systems.

  • Mahowald M (2004)Chronic Pain Management. Kelley’s Textbook of Rheumatology (Ruddy S, E Harris, C Sledge, R Budd and J Sergent, Eds.) (WB Saunders: Philadelphia, PA).

    Google Scholar 

  • Mahowald M (2005) Opioid use by patients in an orthopedics spine clinic.Arth. Rheum. 52, 312–321.

    Article  Google Scholar 

  • Mahowald M, J Singh and P Majeski (2005) Opioid use for chronic spine pain.Arthritis Rheum. 52(1), 312–321.

    Article  PubMed  Google Scholar 

  • Matsen FA 3rd, KL Smith, SE DeBartolo and G Von Oesen (1997) A comparison of patients with late-stage rheumatoid arthritis and osteoarthritis of the shoulder using self-assessed shoulder function and health status.Arthritis Care Res. 10(1), 43–47.

    Article  PubMed  Google Scholar 

  • McAlindon T, C Cooper, J Kirwan, P Dieppe (1992) Knee pain and disability in the community.Br. J. Rheumatol. 23, 189–192.

    Article  Google Scholar 

  • Mena HR, PL Lomen, and LF Turner, KR Lamborn and EL Brinn (1986) Treatment of acute shoulder syndrome with flurbiprofen.Am. J. Med. 80(3A), 141–144.

    Article  CAS  PubMed  Google Scholar 

  • Miller H (1993). Plan and Operation of the Health and Nutrition Examination Survey: United States, 1971–1973. Vital and Health Statistics Series 1. No. 10, Public Health Service, US Department of Health Service.

  • Montecucco C and G Schiavo (1994) Mechanism of action of tetanus and botulinum neurotoxins.Mol. Microbiol. 13(1), 1–8.

    Article  CAS  PubMed  Google Scholar 

  • Montecucco C, G Schiavo and O Rossetto (1996) The mechanism of action of tetanus and botulinum neurotoxins.Arch. Toxicol. Suppl.18, 342–354.

    CAS  PubMed  Google Scholar 

  • Moseley J, K O’Malley, N Petersen, T Menke, B Brody, D Kuykendall, J Hollingsworth, C Ashton, N Wray (2002) A controlled trial of arthroscopic surgery for osteoarthritis of the knee.N. Engl. J. Med. 347, 81–88.

    Article  PubMed  Google Scholar 

  • Newcomer K, H Krug and ML Mahowald (1993) Validity and reliability of the timed-stands test for patients with rheumatoid arthritis and other chronic diseases.J. Rheumatol. 20, 21–27.

    CAS  PubMed  Google Scholar 

  • Petri M, R Dobrow, R Neiman, Q Whiting-O’Keefe and WE Seaman (1987) Randomized, double-blind, placebo-controlled study of the treatment of the painful shoulder.Arthritis Rheum. 30(9), 1040–1045.

    Article  CAS  PubMed  Google Scholar 

  • Porta M (2000) A comparative trial of botulinum toxin thye A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.Pain 85, 101–105.

    Article  CAS  PubMed  Google Scholar 

  • Purkiss JR, MJ Welch, S Doward and KA Foster (1997) Capsaicin stimulates release of substance P from dorsal root ganglion neurons via two distinct mechanisms.Biochem. Soc. Trans. 25(3), 542S.

    CAS  PubMed  Google Scholar 

  • Purkiss J, M Welch, S Doward and K Foster (2000) Capsicin stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.Biochem. Pharmacol. 59, 1403–1406.

    Article  CAS  PubMed  Google Scholar 

  • Reeves B (1975) The natural history of the frozen shoulder syndrome.Scand. J. Rheumatol. 4(4), 193–196.

    Article  CAS  PubMed  Google Scholar 

  • Relja M (2002) Pain responsiveness in cervical dystonia: different doses of botulinum toxin type A.Eur. J. Neurol. 9 (Suppl. 12), 188–189.

    Google Scholar 

  • Richardson AT (1975) Ernest Fletcher Lecture. The painful shoulder.Proc. R. Soc. Med. 68(11), 731–736.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Rizk TE, RS Pinals and AS Talaiver (1991) Corticosteroid injections in adhesive capsulitis: investigation of their value and site.Arch. Phys. Med. Rehabil. 72(1), 20–22.

    CAS  PubMed  Google Scholar 

  • Rowland L (2002) Stroke, spasticity and botulinum toxin.N. Engl. J. Med. 347, 382–383.

    Article  PubMed  Google Scholar 

  • Schantz EJ and EA Johnson (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine.Microbiol. Rev. 56(1), 80–99.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Schiavo G, O Rossetto, A Santucci, BR DasGupta and C Montecucco (1992) Botulinum neurotoxins are zinc proteins.J. Biol. Chem. 267(33), 23479–23483.

    CAS  PubMed  Google Scholar 

  • Schiavo G, A Santucci, BR Dasgupta, PP Mehta, J Jontes, F Benfenati, MC Wilson and C Montecucco (1993) Botulinum neurotoxins sero-types A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds.FEBSLett. 335(1), 99–103.

    Article  CAS  Google Scholar 

  • Scott A (1981) Botulinum toxin injection of eye muscles to correct strabismus.Trans. Am. Ophthamol. Soc. 79, 734–770.

    CAS  Google Scholar 

  • Shaffer B, JE Tibone and RK Kerlan (1992) Frozen shoulder. A long-term follow-up.J. Bone Joint Surg. Am. 74(5), 738–746.

    CAS  PubMed  Google Scholar 

  • Simpson L (1981) The origin, structure, and pharmacological activity of botulinum toxin.Pharmacol. Rev. 33, 155–188.

    CAS  PubMed  Google Scholar 

  • Singh J, ML Mahowald and DD Dykstra (2004) Report on intra-articular botulinum toxin type A for refractory joint pain.J. Pain 5(3) Suppl. 1, S60.

    Article  Google Scholar 

  • Thornhill T (1997).Shoulder Pain. Textbook of Rheumatology (Kelley S, E Ruddy, E Harris and C Sledge, Eds.) (WB Saunders: Philadelphia, PA), 413–438.

    Google Scholar 

  • Turk DC, TE Ruddy and BA Sorkin (1993) Neglected topics in chronic pain treatment outcome studies: determination of success.Pain 53(1), 3–16.

    Article  CAS  PubMed  Google Scholar 

  • van der Heijden GJ, DA van der Windt, J Kleijnen, B W Koes and L M Bouter (1996) Steroid injections for shoulder disorders: a systematic review of randomized clinical trials.Br. J. Gen. Pract. 46(406), 309–316.

    PubMed Central  PubMed  Google Scholar 

  • van der Heijden G, D Van der Windt, A de Winter (1997) Physiotherapy for soft tissue shoulder disorders: a systematic review of randomised clinical trials.Bmj 315, 25–30.

    Article  PubMed Central  PubMed  Google Scholar 

  • van der Windt DA, BW Koes, BA de Jong and LM Bouter (1995a) Shoulder disorders in general practice: incidence, patient characteristics, and management.Ann. Rheum. Dis. 54(12), 959–964.

    Article  PubMed Central  PubMed  Google Scholar 

  • van der Windt DA, GJ van der Heijden, RJ Scholten, BW Koes and LM Bouter (1995b) The efficacy of non-steroidal anti-inflammatory drugs (NSAIDS) for shoulder complaints. A systematic review.J. Clin. Epidemiol. 48(5), 691–704.

    Article  PubMed  Google Scholar 

  • van der Windt DA, BW Koes, W Deville, AJ Boeke, BA de Jong and LM Bouter (1998) Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial.Bmj 317(7168), 1292–1296.

    Article  PubMed Central  PubMed  Google Scholar 

  • Vecchio PC, BL Hazleman and RH King (1993) A double-blind trial comparing subacromial methylprednisolone and lignocaine in acute rotator cuff tendinitis.Br. J. Rheumatol. 32(8), 743–745.

    Article  CAS  PubMed  Google Scholar 

  • Vecchio PC, RT Kavanagh, BL Hazleman and RH King (1995) Community survey of shoulder disorders in the elderly to assess the natural history and effects of treatment.Ann. Rheum. Dis. 54(2), 152–154.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Welch MJ, JR Purkiss and KA Foster (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.Toxicon 38(2), 245–258.

    Article  CAS  PubMed  Google Scholar 

  • Wheeler A (1998) Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension.Headache 38, 468–471.

    Article  CAS  PubMed  Google Scholar 

  • Wheeler A, P Goolkasian and S Gretz (1998) A randomized, double blind, prospecive pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.Spine 23, 1662–1666.

    Article  CAS  PubMed  Google Scholar 

  • White RH, DM Paull and KW Fleming (1986) Rotator cuff tendinitis: comparison of subacromial injection of a long acting corticosteroid versus oral indomethacin therapy.J. Rheumatol. 13(3), 608–613.

    CAS  PubMed  Google Scholar 

  • Winters JC, W Jorritsma, KH Groenier, JS Sobel, B Meyboom-de Jong and HJ Arendzen (1999) Treatment of shoulder complaints in general practice: long term results of a randomised, single blind study comparing physiotherapy, manipulation, and corticosteroid injection.Bmj 318(7195), 1395–1396.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Withrington RH, FL Girgis and MH Seifert (1985) A placebo-controlled trial of steroid injections in the treatment of supraspinatus tendonitis.Scand. J. Rheumatol. 14(1), 76–78.

    Article  CAS  PubMed  Google Scholar 

  • Ytterberg SR, ML Mahowald and SR Woods (1998) Codeine and oxy-codone use in patients with chronic rheumatic disease pain.Arthritis Rheum. 41(9), 1603–1612.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maren L. Mahowald.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahowald, M.L., Singh, J.A. & Dykstra, D. Long term effects of intra-articular botulinum toxin a for refractory joint pain. neurotox res 9, 179–188 (2006). https://doi.org/10.1007/BF03033937

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033937

Keywords

Navigation